AR and adenocarcinoma: Although AR transcriptional activity is low in fully grown NE/SC [1], a substantial fraction (35%) of CRPC with combined biallelic loss of RB1 and TP53 was classified as AR-positive adenocarcinomas without neuroendocrine features [53].